Literature DB >> 20116331

Complement in neuroprotection and neurodegeneration.

Vijay Yanamadala1, Robert M Friedlander.   

Abstract

Acute neurodegeneration is associated with high morbidity and mortality, and there are few effective treatments. Inflammation is central to the process of neuronal death, yet the roles of the complement cascade in this process have proven to be complex and hard to unravel. The complement cascade is involved in triggering cell death and recruiting cells of the immune system to sites of inflammation, including the brain. However, complement might also have important neuroprotective roles that are only now coming to light. Recent evidence suggests that targeted activation of complement might be a potential approach for treatment of stroke and other acute neurodegenerative diseases. Here, we review these novel neuroprotective roles of the complement cascade, focusing on signaling pathways that might provide new therapeutic targets in acute neuronal injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20116331      PMCID: PMC2824068          DOI: 10.1016/j.molmed.2009.12.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  41 in total

Review 1.  Social controls on cell survival and cell death.

Authors:  M C Raff
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

Review 2.  The role of the complement system in innate immunity.

Authors:  Horea Rus; Cornelia Cudrici; Florin Niculescu
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Kinetics of anaphylatoxin C5a receptor expression during experimental allergic encephalomyelitis.

Authors:  S Nataf; N Davoust; S R Barnum
Journal:  J Neuroimmunol       Date:  1998-11-02       Impact factor: 3.478

4.  Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death.

Authors:  J van Beek; O Nicole; C Ali; A Ischenko; E T MacKenzie; A Buisson; M Fontaine
Journal:  Neuroreport       Date:  2001-02-12       Impact factor: 1.837

5.  Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation.

Authors:  L Soane; H Rus; F Niculescu; M L Shin
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

6.  Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.

Authors:  S K Singhrao; J W Neal; N K Rushmere; B P Morgan; P Gasque
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

7.  Complement: a novel factor in basal and ischemia-induced neurogenesis.

Authors:  Yalda Rahpeymai; Max Albert Hietala; Ulrika Wilhelmsson; Andrew Fotheringham; Ioan Davies; Ann-Katrin Nilsson; Jörg Zwirner; Rick A Wetsel; Craig Gerard; Milos Pekny; Marcela Pekna
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

8.  Role of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum.

Authors:  Magalie Bénard; Emilie Raoult; David Vaudry; Jérome Leprince; Anthony Falluel-Morel; Bruno J Gonzalez; Ludovic Galas; Hubert Vaudry; Marc Fontaine
Journal:  Mol Immunol       Date:  2008-07-16       Impact factor: 4.407

Review 9.  Cell death: apoptosis versus necrosis (review).

Authors:  Darja Kanduc; Abraham Mittelman; Rosario Serpico; Eberta Sinigaglia; Animesh A Sinha; Costanzo Natale; Raffaella Santacroce; M Grazia Di Corcia; Alberta Lucchese; Luciana Dini; Paolo Pani; Salvatore Santacroce; Simone Simone; Romano Bucci; Emanuel Farber
Journal:  Int J Oncol       Date:  2002-07       Impact factor: 5.650

10.  Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice.

Authors:  Philip F Stahel; Michael A Flierl; B Paul Morgan; Ivonne Persigehl; Christiane Stoll; Claudia Conrad; Basel M Touban; Wade R Smith; Kathryn Beauchamp; Oliver I Schmidt; Wolfgang Ertel; Iris Leinhase
Journal:  J Neuroinflammation       Date:  2009-01-08       Impact factor: 8.322

View more
  27 in total

Review 1.  Dynamic control of the complement system by modulated expression of regulatory proteins.

Authors:  Joshua M Thurman; Brandon Renner
Journal:  Lab Invest       Date:  2010-10-04       Impact factor: 5.662

Review 2.  The Role of Complement C3a Receptor in Stroke.

Authors:  Saif Ahmad; Kanchan Bhatia; Adam Kindelin; Andrew F Ducruet
Journal:  Neuromolecular Med       Date:  2019-05-17       Impact factor: 3.843

3.  Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study.

Authors:  Matthew Zabel; Matthew Schrag; Claudius Mueller; Weidong Zhou; Andrew Crofton; Floyd Petersen; April Dickson; Wolff M Kirsch
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia.

Authors:  Franca Orsini; Pia Villa; Sara Parrella; Rosalia Zangari; Elisa R Zanier; Raffaella Gesuete; Matteo Stravalaci; Stefano Fumagalli; Roberta Ottria; José J Reina; Alessandra Paladini; Edoardo Micotti; Renato Ribeiro-Viana; Javier Rojo; Vasile I Pavlov; Gregory L Stahl; Anna Bernardi; Marco Gobbi; Maria-Grazia De Simoni
Journal:  Circulation       Date:  2012-08-09       Impact factor: 29.690

Review 5.  Disease-causing mutations in genes of the complement system.

Authors:  Søren E Degn; Jens C Jensenius; Steffen Thiel
Journal:  Am J Hum Genet       Date:  2011-06-10       Impact factor: 11.025

6.  Alternative complement pathway is activated in the brains of scrapie-infected rodents.

Authors:  Cao Chen; Yan Lv; Chao Hu; Xiao-Feng Xu; Ren-Qing Zhang; Kang Xiao; Yue Ma; Li-Ping Gao; Jian-Le Li; Qiang Shi; Jing Wang; Qi Shi; Xiao-Ping Dong
Journal:  Med Microbiol Immunol       Date:  2019-11-12       Impact factor: 3.402

7.  Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.

Authors:  Julien Ratelade; Hua Zhang; Samira Saadoun; Jeffrey L Bennett; Marios C Papadopoulos; A S Verkman
Journal:  Acta Neuropathol       Date:  2012-04-22       Impact factor: 17.088

8.  Role of C/EBP-β, p38 MAPK, and MKK6 in IL-1β-mediated C3 gene regulation in astrocytes.

Authors:  Jeffrey Maranto; Jay Rappaport; Prasun K Datta
Journal:  J Cell Biochem       Date:  2011-04       Impact factor: 4.429

Review 9.  Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease.

Authors:  Hong Lian; Hui Zheng
Journal:  J Neurochem       Date:  2015-11-30       Impact factor: 5.372

10.  Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis.

Authors:  Bianca Woehrl; Matthijs C Brouwer; Carmen Murr; Sebastiaan G B Heckenberg; Frank Baas; Hans W Pfister; Aeilko H Zwinderman; B Paul Morgan; Scott R Barnum; Arie van der Ende; Uwe Koedel; Diederik van de Beek
Journal:  J Clin Invest       Date:  2011-09-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.